Lyme disease vaccine 70 percent effective
Digest more
In today’s Health Alert, Pfizer’s Lyme vaccine shows strong protection in a phase 3 clinical trial, but misses a key study ...
March 23 (Reuters) - U.S. drugmaker Pfizer and France's Valneva said on Monday their experimental Lyme disease vaccine showed more than 70% efficacy in a late-stage trial. Pfizer said it had planned ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results